1. Home
  2. PPL vs NTRA Comparison

PPL vs NTRA Comparison

Compare PPL & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PPL Corporation

PPL

PPL Corporation

HOLD

Current Price

$38.16

Market Cap

28.9B

Sector

Utilities

ML Signal

HOLD

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$200.12

Market Cap

28.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PPL
NTRA
Founded
1920
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Medical Specialities
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.9B
28.0B
IPO Year
2007
2015

Fundamental Metrics

Financial Performance
Metric
PPL
NTRA
Price
$38.16
$200.12
Analyst Decision
Buy
Strong Buy
Analyst Count
12
14
Target Price
$40.00
$259.07
AVG Volume (30 Days)
6.8M
1.1M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
3.00%
N/A
EPS Growth
32.50
0.65
EPS
1.59
N/A
Revenue
$9,042,000,000.00
$210,939,000.00
Revenue This Year
$6.76
$18.16
Revenue Next Year
$6.09
$20.00
P/E Ratio
$23.94
N/A
Revenue Growth
6.85
N/A
52 Week Low
$32.50
$125.38
52 Week High
$39.09
$256.36

Technical Indicators

Market Signals
Indicator
PPL
NTRA
Relative Strength Index (RSI) 55.59 50.15
Support Level $35.31 $194.03
Resistance Level $38.20 $204.34
Average True Range (ATR) 0.66 7.31
MACD -0.04 0.46
Stochastic Oscillator 63.56 82.21

Price Performance

Historical Comparison
PPL
NTRA

About PPL PPL Corporation

PPL is a holding company of regulated utilities in Pennsylvania, Kentucky, and Rhode Island. The Pennsylvania regulated delivery and transmission segment distributes electricity to customers in central and eastern Pennsylvania. In Kentucky, LG&E and KU are involved in regulated electricity generation, transmission, and distribution. LG&E also provides regulated natural gas distribution. Rhode Island Energy operates electric and gas utilities in the state.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: